Excess mortality among HIV-infected patients diagnosed with substance use dependence or abuse receiving care in a fully integrated medical care program
- PMID: 21058961
- PMCID: PMC3242701
- DOI: 10.1111/j.1530-0277.2010.01335.x
Excess mortality among HIV-infected patients diagnosed with substance use dependence or abuse receiving care in a fully integrated medical care program
Abstract
Background: We examined the association between substance use (SU) disorder and mortality among HIV-infected patients in a large, private medical care program.
Methods: In a retrospective cohort design, HIV-infected patients (≥14 years old) from a large health plan (Northern California) were studied to examine mortality associated with diagnosis of SU dependence or abuse over an 11-year period.
Results: At study entry or during follow-up, 2,279 (25%) of 9,178 HIV-infected patients had received a diagnosis of SU disorder. Diagnoses were categorized as alcohol dependence/abuse only, illicit drugs only, or both. Cause of death differed by the category of SU diagnosis. Mortality rates ranged from 35.5 deaths per 1,000 person-years in patients with an SU disorder to 17.5 deaths among patients without an SU disorder. Regression results indicated mortality risk was significantly higher in all categories of SU disorder compared to no SU diagnosis (hazard ratios ranging from 1.65 to 1.67) after adjustment for SU treatment and confounders.
Conclusions: A diagnosis of SU dependence/abuse is associated with higher mortality among HIV-infected patients for whom access to medical services is not a significant factor.
Copyright © 2010 by the Research Society on Alcoholism.
Conflict of interest statement
CONFLICT OF INTEREST
This study was approved by the Institutional Review Boards of Kaiser Permanente Northern California and the University of California, San Francisco.
Figures
Similar articles
-
Mortality after diagnosis of psychiatric disorders and co-occurring substance use disorders among HIV-infected patients.AIDS Patient Care STDS. 2010 Nov;24(11):705-12. doi: 10.1089/apc.2010.0139. Epub 2010 Oct 23. AIDS Patient Care STDS. 2010. PMID: 20969465 Free PMC article.
-
The role of HIV infection and drug and alcohol dependence in hospital mortality among critically ill patients.J Crit Care. 2008 Sep;23(3):275-80. doi: 10.1016/j.jcrc.2007.04.001. Epub 2007 Jul 5. J Crit Care. 2008. PMID: 18725029
-
Recent drug use, homelessness and increased short-term mortality in HIV-infected persons with alcohol problems.AIDS. 2008 Jan 30;22(3):415-20. doi: 10.1097/QAD.0b013e3282f423f8. AIDS. 2008. PMID: 18195568 Free PMC article.
-
Substance abuse, adherence with antiretroviral therapy, and clinical outcomes among HIV-infected individuals.Life Sci. 2011 May 23;88(21-22):948-52. doi: 10.1016/j.lfs.2010.09.025. Epub 2010 Oct 1. Life Sci. 2011. PMID: 20888839 Free PMC article. Review.
-
Smoking, alcohol and illicit drug use effects on survival in HIV-positive persons.Curr Opin HIV AIDS. 2016 Sep;11(5):514-520. doi: 10.1097/COH.0000000000000306. Curr Opin HIV AIDS. 2016. PMID: 27327615 Review.
Cited by
-
A Randomized Trial Comparing Brief Advice and Motivational Interviewing for Persons with HIV-HCV Co-infection Who Drink Alcohol.AIDS Behav. 2021 Apr;25(4):1013-1025. doi: 10.1007/s10461-020-03062-2. Epub 2020 Oct 12. AIDS Behav. 2021. PMID: 33047258 Clinical Trial.
-
Motivational interviewing with personalized feedback to reduce alcohol use in HIV-infected men who have sex with men: A randomized controlled trial.J Consult Clin Psychol. 2018 Aug;86(8):645-656. doi: 10.1037/ccp0000322. J Consult Clin Psychol. 2018. PMID: 30035581 Free PMC article. Clinical Trial.
-
Alcohol use disorder and its impact on chronic hepatitis C virus and human immunodeficiency virus infections.World J Hepatol. 2016 Nov 8;8(31):1295-1308. doi: 10.4254/wjh.v8.i31.1295. World J Hepatol. 2016. PMID: 27872681 Free PMC article. Review.
-
Reducing heavy drinking in HIV primary care: a randomized trial of brief intervention, with and without technological enhancement.Addiction. 2013 Jul;108(7):1230-40. doi: 10.1111/add.12127. Epub 2013 Apr 17. Addiction. 2013. PMID: 23432593 Free PMC article. Clinical Trial.
-
Opioid misuse among persons with HIV engaged in care in the Southeastern US.AIDS Care. 2021 Feb;33(2):148-153. doi: 10.1080/09540121.2019.1699644. Epub 2019 Dec 8. AIDS Care. 2021. PMID: 31814449 Free PMC article.
References
-
- Basu S, Smith-Rohrberg D, Bruce RD, Altice FL. Models for integrating buprenorphine therapy into the primary HIV care setting. Clin Infect Dis. 2006;42:716–721. - PubMed
-
- Breslow NE, Day NE. Statistical methods in cancer research. Volume II – the design and analysis of cohort studies. IARC Sci Publ. 1987;82:1–406. - PubMed
-
- Conigliaro J, Madenwald T, Bryant K, Braithwaite S, Gordon A, Fultz SL, Maisto S, Samet J, Kraemer K, Cook R, Day N, Roach D, Richey S, Justice A. The Veterans Aging Cohort Study: observational studies of alcohol use, abuse, and outcomes among human immunodeficiency virus-infected veterans. Alcohol Clin Exp Res. 2004;28:313–321. - PubMed
-
- Detels R, Munoz A, McFarlane G, Kingsley LA, Margolick JB, Giorgi J, Schrager LK, Phair JP. Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. Multicenter AIDS Cohort Study Investigators. JAMA. 1998;280:1497–1503. - PubMed
-
- Estrada AL. Health disparities among African-American and Hispanic drug injectors – HIV, AIDS, hepatitis B virus and hepatitis C virus: a review. AIDS. 2005;19(Suppl 3):S47–S52. - PubMed